OSU molecular geneticist wins NSF award for most promising young scientists

Ohio State Universty Assistant Professor of Molecular Genetics Keith Slotkin has received the National Science Foundation’s highest award for the country’s most promising young scientists, the NSF CAREER Award.

These grants are given to researchers who early in their careers have clearly demonstrated their potential for making significant discoveries in their fields. Slotkin studies transposable elements, sometimes called “jumping genes,” that are stretches of DNA that can duplicate or move from one location in the genome to another.

“These are fragments of DNA that reside in the genomes of multicellular organisms,” Slotkin said. “They’re not considered actual genes, but they’re like little genomic parasites. They are out only to duplicate themselves—not to help the organism they reside in.”

Their highly-successful ability to do just that has resulted in transposable elements occupying vast amounts of most plant and animal genomes. “For example, they occupy nearly half of the human genome, and 85% of corn,” Slotkin said.

Although often overlooked or dismissed as “junk DNA,” transposable elements have played an important role in the structure and evolution of these genomes.

One of the key questions is why transposable elements have been conserved through time.

“Maybe,” Slotkin said, “they have a key function in the organism. But we don’t yet know whether they are pure parasites or have another function.

“But we do know that when transposable elements are active—that is when they ‘jump,’ they cause damage, which includes chromosome breakage, instability, and disease and can destroy an organism very quickly from inside.”

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Philips Healthcare resumes medical imaging manufacturing in Highland Heights | Crains Cleveland, October 23, 2014

HealthSpot wins telemedicine fans in Cleveland, but Nationwide Children’s presses pause | Columbus Business First, October 23, 2014

NuVasive Manufacturing in Fairborn adding 35 positions, double production during the next three to five years | Dayton Business Journal, October 22, 2014

STERIS relocating global specialty services HQ to Birmingham, AL, hiring 200 | Birmingham Business Journal, October 22, 2014

Porter Wright getting new managing partner, Bob Tannous will take over for Robert Trafford | Columbus Business First, October 22, 2014

Cardinal Health donates one million medical products to help fight Ebola in West Africa | The Columbus Dispatch, October 21, 2014

Procter & Gamble hiring soon for distribution center in Union’s Global Logistics Airpark | WDTN2 News, October 21, 2014

Central Ohio career technical education partnerships are shaping tomorrow’s workforce today | Columbus CEO, October 21, 2014

NanoLogix developing rapid test for Ebola virus (video) | WYTV33 Youngstown, October 21, 2014

Analytic, a partnership of Anatrace and Microlytic: enabling membrane protein research | PR Web, October 21, 2014

Quasar Energy Group uses organic waste to produce renewable energy | Todays Energy Solutions, October 21, 2014

Frank Samuel, President of VentureOhio and former BioOhio President dies in auto accident | Geauga County Maple Leaf, October 21, 2014

X-spine announces launch of Axograft Biologics Portfolio | X-Spine, October 20, 2014

Milo Biotechnology’s follistatin gene therapy increases function in Becker Muscular Dystrophy patients | PR Newswire, October 20, 2014

Skilled Care Pharmacy and Assurex Health announce partnership to provide GeneSight genetic test | Assurex Health, October 20, 2014

Mayo Clinic and Cleveland Clinic latest to deploy HealthSpot telemedicine booths | Columbus Business First, October 20, 2014

OSU Wexner Medical Center study: new implantable device to control heart failure shows promising results | Todays Medical Developments, October 17, 2014

Assurex Health gets $6M funding for clinical trial related to patients with depression or schizophrenia | Cincinnati Business Courier, October 17, 2014

University of Cincinnati lands grant to attack hepatitis C among needle users in 20 counties | WCPO9 Cincinnati, October 16, 2014

Control Bionics interview, developing technology that enables individuals with debilitating conditions to communicate | The Clermont Sun, October 16, 2014